Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02283918 · ClinicalTrials.gov registry record
Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery
A clinical trial, sponsored by Biogen.
- Completed
- Registry status
- 467
- Enrollment target
NCT02283918 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 467 participants.
The verdict
NCT02283918 has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 467 participants
- Enrollment target
Study Summary
The primary objective of the study is to develop MS patient-matched healthy population norms for the Multiple Sclerosis Cognition Assessment Battery (MS-COG) that are representative of the United States (US), France, and Italy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 467 participants |
| Start Date | 2014-11 |
| Est. Completion | 2015-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02283918
The ClinicalTrials.gov registry entry for NCT02283918 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 467 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02283918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02283918 about?
NCT02283918 is a clinical study titled "Observational Study to Establish Patient-Matched Population Norms for the Multiple Sclerosis Cognition Assessment Battery". The primary objective of the study is to develop MS patient-matched healthy population norms for the Multiple Sclerosis Cognition Assessment Battery (MS-COG) that are representative of the United States (US), France, and Italy.
What is the current status of trial NCT02283918?
This trial is currently completed. The enrollment target is 467 participants. The study started on 2014-11. Estimated completion is 2015-08.
Who is sponsoring clinical trial NCT02283918?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.